$ORTX Orchard Therapeutics plc Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Orchard Therapeutics plc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Orchard Therapeutics plc. Insider overview, share value development, latest insider transactions and email notifications about new events in Orchard Therapeutics plc for free.

CIK Number: 0001748907
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ORTX
Company Address: 108 CANNON STREET LONDON EC4N 6EU
Former name: Orchard Rx Ltd, date of change: 2018-08-02

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.

Orchard Therapeutics plc Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Gaspar BobbyChief Executive Officer353,2400shares bought: 4,921 / shares sold: -4,921 HOLDApr 03 20202 months ago
THOMAS FRANK ESee Remarks00Apr 03 20202 months ago

View all Orchard Therapeutics plc insiders.

Orchard Therapeutics plc Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 03 2020ORTXOrchard Therapeuti ...Gaspar BobbyChief Executive Off ...Option ExerciseA7.05300,0002,115,000300,000
Apr 03 2020ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksOption ExerciseA7.05150,0001,057,500150,000
Mar 04 2020ORTXOrchard Therapeuti ...Gaspar BobbySee RemarksOption ExerciseM0.004,9210597,867
Mar 04 2020ORTXOrchard Therapeuti ...Gaspar BobbySee RemarksSellS13.004,92163,973348,319353.2 K to 348.3 K (-1.39 %)
Mar 04 2020ORTXOrchard Therapeuti ...Gaspar BobbySee RemarksBuyM0.004,9210353,240348.3 K to 353.2 K (+1.41 %)
Feb 03 2020ORTXOrchard Therapeuti ...Altschuler StevenDirectorOption ExerciseA12.3050,000615,00050,000
Jan 06 2020ORTXOrchard Therapeuti ...FMR LLC10% OwnerBuyS13.418,753117,3786,122,2956.1 M to 6.1 M (+0.14 %)
Jan 06 2020ORTXOrchard Therapeuti ...FMR LLC10% OwnerSellS13.555,48474,3086,131,0486.1 M to 6.1 M (-0.09 %)
Jan 06 2020ORTXOrchard Therapeuti ...FMR LLC10% OwnerSellS13.418,753117,3786,122,2956.1 M to 6.1 M (-0.14 %)
Jan 06 2020ORTXOrchard Therapeuti ...FMR LLC10% OwnerSellS13.555,48474,3086,131,0486.1 M to 6.1 M (-0.09 %)
Jan 06 2020ORTXOrchard Therapeuti ...THOMAS FRANK ESee RemarksOption ExerciseA13.58200,0002,716,000200,000

View all Orchard Therapeutics plc insider transactions.